NorMIGS - a Study of Micro-invasive Glaucoma Surgery
Recruiting · NCT05340647 · Observational (researchers observe without assigning treatment) · Lead sponsor: Oslo University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Other MIGSPreserflo microshuntTrabeculectomy
What this trial is about
NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
- Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS
- Ability to cooperate fairly well during the examinations
- Willing to participate in the study and capable of providing informed consent
Exclusion criteria
- \- High intraocular pressure due to increased episcleral venous pressure, hemorrhagic glaucoma, traumatic glaucoma or uveitis glaucoma
Where it is running
1 location listed.
- Department of Ophthalmology, Oslo University Hospital - Oslo, Norway